Self-limited poxvirus infection producing small dome-shaped umbilicated papules; common in children and immunocompromised adults.
Also known as: molluscum, molluscum contagiosum, MC
Overview
A common cutaneous infection caused by the Molluscum contagiosum virus (MCV), a double-stranded DNA poxvirus. Produces small, dome-shaped, flesh-colored to pearly-white umbilicated papules.
Epidemiology
Worldwide distribution; ~5% prevalence in children. Peak ages 2-5 years and sexually active young adults. Increased prevalence and severity in atopic dermatitis and HIV/immunocompromised.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Molluscum Contagiosum outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Children in close contact (daycare, siblings, swimming pools, shared towels)
Atopic dermatitis (impaired barrier, autoinoculation through scratching)
Sexual contact (genital molluscum in adults)
Immunosuppression — HIV (particularly when CD4 <100), transplant, biologics; lesions can become large, numerous, and refractory
Wrestlers, swimmers, gym users
Pathophysiology
MCV is the only poxvirus that infects humans without systemic spread. Infects keratinocytes through microabrasions; replicates entirely in the cytoplasm. Forms characteristic intracytoplasmic inclusion bodies (Henderson-Patterson 'molluscum bodies'). Spread by direct skin contact, fomites, and autoinoculation; incubation 2-7 weeks (range 1 week to 6 months).
Clinical presentation
Symptoms
Usually asymptomatic; cosmetic concern
Pruritus from associated dermatitis around lesions ('molluscum dermatitis')
Tenderness if secondarily infected (BOTE — beginning of the end — sign: erythema and inflammation precedes spontaneous resolution)
Signs / physical exam
Discrete 2-5 mm (occasionally up to 1-2 cm 'giant molluscum') dome-shaped flesh-colored to pearly-white papules with central umbilication (depression containing white waxy core)
Distribution in children: trunk, axillae, antecubital and popliteal fossae, face; spares palms and soles
Distribution in adults: genitalia, lower abdomen, inner thighs (sexually transmitted), or face (after shaving — autoinoculation)
Clinical: characteristic umbilicated papules; dermoscopy and histology in atypical cases.
Labs
Clinical diagnosis sufficient in most cases
Dermoscopy: central polylobular yellow-white amorphous structure with crown vessels
Expression of core onto slide with KOH or stain (Wright, Giemsa) shows Henderson-Patterson bodies
Biopsy if atypical, atypical site (palms/soles), or to exclude cryptococcosis in HIV
HIV testing in adults with extensive or facial molluscum without clear risk factor
Imaging
Not indicated
Diagnostic algorithm
Setting
Approach
Healthy child, asymptomatic
Active observation — resolves in 6-12 months
Bothersome / cosmetic / autoinoculating
Cantharidin in office; curettage; berdazimer gel
Adult genital molluscum
Treat lesions + screen STIs + counsel partner
Eyelid involvement
Refer ophthalmology before destructive therapy
Immunocompromised / HIV
Optimize ART; multimodal therapy; biopsy to exclude cryptococcosis
Molluscum contagiosum management by clinical setting.
Treatment
First-line
Active observation — molluscum is self-limited and resolves spontaneously in healthy children within 6-12 months (occasionally up to 4 years); no scarring
Cantharidin 0.7% in office — applied to each lesion, covered with tape, washed off in 2-6 hours; produces blister and resolution; well-tolerated in children (avoid face and genitals)
Berdazimer 10.3% topical gel — FDA-approved 2024 for ages ≥1 year; applied daily × up to 12 weeks
Cryotherapy (light liquid nitrogen) — quick, can be painful, hypopigmentation risk in skin of color
Curettage — removes lesion immediately; topical anesthetic before; small risk of scarring
Topical retinoids (tretinoin 0.05%) for flat lesions
KOH 10% topical (some studies show efficacy)
Imiquimod 5% has shown disappointing results in pediatric trials and is no longer recommended
Treat associated eczematous dermatitis with low-mid potency topical corticosteroid
Sexually transmitted (adult genital)
Same modalities as cutaneous, plus screen and treat partners
Counsel on condom use (incomplete protection)
Screen for other STIs
Immunocompromised (HIV, CD4 <100)
Initiate or optimize antiretroviral therapy — single most effective intervention
Combine destructive techniques (curettage, cryotherapy) with topical/systemic agents
Rule out cryptococcosis and other disseminated mycoses in atypical lesions
Second-line / adjunct
Intralesional candida antigen, interferon, or cidofovir (topical or IV) for refractory disease in immunocompromised
Hygiene counseling: avoid sharing towels, swimsuits, baths until resolved; do not pick or scratch lesions
Complications
Bacterial superinfection from scratching
Scarring (rare; mostly from destructive treatment)
Post-inflammatory hyper/hypopigmentation
Eyelid involvement → conjunctivitis or keratitis (refer to ophthalmology)
Extensive disease as marker of HIV/immunosuppression
Eczematous molluscum dermatitis and reactive id reactions
Sexual transmission stigma and partner concerns in adults
PANCE pearls
Umbilicated dome-shaped flesh-colored papules in a child = molluscum until proven otherwise.
BOTE sign (beginning of the end) — sudden inflammation, erythema, and crusting of a molluscum lesion heralds spontaneous resolution; do not treat as bacterial infection.
Numerous, large, or facial molluscum in an adult should prompt HIV testing — and consider cryptococcosis if CD4 <100.
Cantharidin is the preferred in-office treatment in pediatrics — painless on application, blister forms hours later.
Active observation is appropriate and evidence-based for healthy children; aggressive treatment is rarely required.
References
AAD 2023 — Management of Molluscum Contagiosum (AAD work group review)
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.